In various models of allergic asthma, antibody-blockade of IL-25 inhibited its established ability to increase eosinophil infiltration, increase concentrations of IL-5 and IL-13, increase airway hyperresponsiveness, and induce goblet cell hyperplasia and serum IgE secretion24, 25, 26. The gene discussed is IL5; the disease is airway hyperresponsiveness.